ask="N/A"
ask_size="N/A"
average_daily_volume="336047"
bid="N/A"
bid_size="N/A"
book_value="6.84"
change="N/A"
change_from_200_day_moving_average="2.13"
change_from_50_day_moving_average="-1.00"
change_from_52_week_high="-17.78"
change_From_52_week_low="36.98"
change_in_percent="N/A"
close="70.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.54"
ebitda="26.14M"
eps_estimate_current_year="4.13"
eps_estimate_next_quarter="1.59"
eps_estimate_next_year="4.72"
ex_dividend_date="N/A"
float_shares="8147000"
high="N/A"
high_52_weeks="87.78"
last_trade_date="2/13/2017"
last_trade_price="70.00"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="33.02"
market_capitalization="1.08B"
moving_average_200_day="67.87"
moving_average_50_day="71.00"
name="Eagle Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="84.50"
open="N/A"
pe_ratio="45.57"
peg_ratio="1.13"
percent_change_from_200_day_moving_average="+3.14%"
percent_change_from_50_day_moving_average="-1.41%"
percent_change_from_52_week_high="-20.25%"
percent_change_from_52_week_low="+111.99%"
previous_close="70.00"
price_eps_estimate_current_year="16.99"
price_eps_Estimate_next_year="14.83"
price_per_book="10.24"
price_per_sales="8.54"
revenue="126.52M"
shares_outstanding="15435000"
short_ratio="7.53"
stock_exchange="NGM"
symbol="EGRX"
volume="0"
weeks_range_52="33.02 - 87.78"
